These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17322161)

  • 21. Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients.
    Mellen CK; Ford M; Rindone JP
    Br J Clin Pharmacol; 2010 Jul; 70(1):139-42. PubMed ID: 20642557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible interaction between warfarin and cranberry juice.
    Sylvan L; Justice NP
    Am Fam Physician; 2005 Sep; 72(6):1000; author reply 1000. PubMed ID: 16190498
    [No Abstract]   [Full Text] [Related]  

  • 23. Cranberry juice and warfarin: when bad publicity trumps science.
    Zikria J; Goldman R; Ansell J
    Am J Med; 2010 May; 123(5):384-92. PubMed ID: 20399311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it OK to drink cranberry juice if I take Coumadin?
    Mayo Clin Womens Healthsource; 2011 Jan; 15(1):8. PubMed ID: 21124269
    [No Abstract]   [Full Text] [Related]  

  • 25. Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding rates.
    Lund K; Gaffney D; Spooner R; Etherington AM; Tansey P; Tait RC
    Br J Haematol; 2012 Jul; 158(2):256-261. PubMed ID: 22571356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fatal bleeding under warfarin plus cranberry juice. Is it due to salicylic acid?].
    Isele H
    MMW Fortschr Med; 2004 Mar; 146(11):13. PubMed ID: 15152759
    [No Abstract]   [Full Text] [Related]  

  • 27. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
    Shaw K; Amstutz U; Hildebrand C; Rassekh SR; Hosking M; Neville K; Leeder JS; Hayden MR; Ross CJ; Carleton BC
    Pediatr Blood Cancer; 2014 Jun; 61(6):1055-62. PubMed ID: 24474498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probable interaction between warfarin and torsemide.
    Bird J; Carmona C
    Ann Pharmacother; 2008 Dec; 42(12):1893-8. PubMed ID: 19017829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bidirectional Influences of Cranberry on the Pharmacokinetics and Pharmacodynamics of Warfarin with Mechanism Elucidation.
    Yu CP; Yang MS; Hsu PW; Lin SP; Hou YC
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interaction between Waran and cranberry juice].
    Niklasson A; Andrén L
    Lakartidningen; 2006 Mar 15-21; 103(11):853-4. PubMed ID: 16613116
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probable warfarin and dapsone interaction.
    Truong T; Haley J
    Clin Appl Thromb Hemost; 2012; 18(1):107-9. PubMed ID: 21890570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of Cranberry: Evaluation of Evidence of Kidney Stone Formation and Botanical Drug-Interactions.
    Madden E; McLachlan C; Oketch-Rabah H; Calderón AI
    Planta Med; 2021 Aug; 87(10-11):803-817. PubMed ID: 34015833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible interaction between warfarin and Lycium barbarum L.
    Lam AY; Elmer GW; Mohutsky MA
    Ann Pharmacother; 2001 Oct; 35(10):1199-201. PubMed ID: 11675844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential interaction between pomegranate juice and warfarin.
    Komperda KE
    Pharmacotherapy; 2009 Aug; 29(8):1002-6. PubMed ID: 19637955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
    Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
    Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication.
    Malhi H; Atac B; Daly AK; Gupta S
    Postgrad Med J; 2004 Feb; 80(940):107-9. PubMed ID: 14970301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cranberry juice and warfarin: okay together?
    Harv Health Lett; 2007 Oct; 32(12):6. PubMed ID: 18246623
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.
    Ufer M
    Clin Pharmacokinet; 2005; 44(12):1227-46. PubMed ID: 16372822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin resistance.
    Sinxadi P; Blockman M
    Cardiovasc J Afr; 2008; 19(4):215-7. PubMed ID: 18776969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.